MIGRANAL NASAL SPRAY 4MG/ML
Google image searchProduct monograph
Active ingredient
dihydroergotamine mesylate, 0.5 MG/ACT
DIN: 02228947
Dosage form(s): LIQUID
Route(s) of administration: NASAL
Schedule: Prescription
Company: STERIMAX INC
Date: 01-NOV-2004
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
- N02CA — Ergot alkaloids (ATC, ATC/DDD)
- N02CA01 — DIHYDROERGOTAMINE (ATC/DDD)
Pharmaceutical standard: MFR
